Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Human Aquaporin 4281-300 Is the Immunodominant Linear Determinant in the Context of HLA-DRB1*03:01: Relevance for Diagnosing and Monitoring Patients With Neuromyelitis OpticaImmunodominant Linear Determinants of hAQP4.
Cortico-muscular coherence as an index of fatigue in multiple sclerosis.
T-cell trafficking in the central nervous system.
Neurocardiogenic Pulmonary Oedema: Initial Presentation of Multiple Sclerosis.
The benefits and detriments of macrophages/microglia in models of multiple sclerosis.
Understanding Tremor in Multiple Sclerosis: Prevalence, Pathological Anatomy, and Pharmacological and Surgical Approaches to Treatment.
Accelerometry Reveals Differences in Gait Variability Between Patients with Multiple Sclerosis and Healthy Controls.
A randomized clinical trial of valacyclovir in multiple sclerosis.
Network-Based Multiple Sclerosis Pathway Analysis with GWAS Data from 15,000 Cases and 30,000 Controls.
Effects of adjunct low-dose vitamin d on relapsing-remitting multiple sclerosis progression: preliminary findings of a randomized placebo-controlled trial.
Fenofibrate Inhibited the Differentiation of T Helper 17 Cells In Vitro.
Visual evoked potentials in early diagnosis of demyelinating diseases - a case report of Devic's disease.
Tumefactive multiple sclerosis lesions in two patients after cessation of fingolimod treatment.
CXCR7 suppression modulates microglial chemotaxis to ameliorate experimentally-induced autoimmune encephalomyelitis.
Cognitive assessment in MS.
CCR2+CCR5+ T Cells Producing Matrix Metalloproteinase-9 and Osteopontin in the Pathogenesis of Multiple Sclerosis.
Casting light on multiple sclerosis heterogeneity: the role of HLA-DRB1 on spinal cord pathology.
The role of endogenous antiradical protective system in multiple sclerosis.
Environment may play significant role in multiple sclerosis.
Fatigue and health-related quality of life in relapsing-remitting multiple sclerosis after 2 years glatiramer acetate treatment are predicted by changes at 6 months: an observational multi-center study.
Cognitive functioning and subjective quality of life in relapsing-remitting multiple sclerosis patients before and after percutaneous transluminal angioplasty: a preliminary report.
Assessment of the reproducibility of oligoclonal IgM band detection for its application in daily clinical practice.
MRI measures should be a primary outcome endpoint in phase III randomised controlled trials in multiple sclerosis: Commentary.
Regional anesthesia in patients with pre-existing neurologic disease.
[Interferon-β1b in multiple sclerosis therapy : More than 20 years clinical experience.]

Pages